Literature DB >> 25378809

Catalytic Enantioselective Allylic Amination of Olefins for the Synthesis of ent-Sitagliptin.

Hongli Bao1, Liela Bayeh1, Uttam K Tambar1.   

Abstract

The presence of nitrogen atoms in most chiral pharmaceutical drugs has motivated the development of numerous strategies for the synthesis of enantioenriched amines. Current methods are based on the multi-step transformation of pre-functionalized allylic electrophiles into chiral allylic amines. The enantioselective allylic amination of unactivated olefins represents a more direct and attractive strategy. We report the enantioselective synthesis of ent-sitagliptin via an allylic amination of an unactivated terminal olefin.

Entities:  

Keywords:  amination; asymmetric catalysis; drugs; palladium; rearrangement

Year:  2013        PMID: 25378809      PMCID: PMC4219538          DOI: 10.1055/s-0033-1340079

Source DB:  PubMed          Journal:  Synlett        ISSN: 0936-5214            Impact factor:   2.454


  20 in total

1.  Allylic Amination.

Authors:  Mogens Johannsen; Karl Anker Jørgensen
Journal:  Chem Rev       Date:  1998-06-18       Impact factor: 60.622

Review 2.  Catalytic C-H amination: recent progress and future directions.

Authors:  Florence Collet; Robert H Dodd; Philippe Dauban
Journal:  Chem Commun (Camb)       Date:  2009-07-07       Impact factor: 6.222

3.  Recent advances in catalytic intramolecular C-H aminations.

Authors:  Huw M L Davies; Matthew S Long
Journal:  Angew Chem Int Ed Engl       Date:  2005-06-06       Impact factor: 15.336

Review 4.  Making carbon-nitrogen bonds in biological and chemical synthesis.

Authors:  Ryan Hili; Andrei K Yudin
Journal:  Nat Chem Biol       Date:  2006-06       Impact factor: 15.040

5.  Mechanistically driven development of iridium catalysts for asymmetric allylic substitution.

Authors:  John F Hartwig; Levi M Stanley
Journal:  Acc Chem Res       Date:  2010-09-28       Impact factor: 22.384

6.  Catalytic C-H amination: the stereoselectivity issue.

Authors:  Florence Collet; Camille Lescot; Philippe Dauban
Journal:  Chem Soc Rev       Date:  2011-01-13       Impact factor: 54.564

Review 7.  Discovery of JANUVIA (Sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

Authors:  Nancy A Thornberry; Ann E Weber
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

8.  Catalytic enantioselective allylic amination of unactivated terminal olefins via an ene reaction/[2,3]-rearrangement.

Authors:  Hongli Bao; Uttam K Tambar
Journal:  J Am Chem Soc       Date:  2012-10-29       Impact factor: 15.419

Review 9.  C-C, C-O, C-N bond formation on sp2 carbon by Pd(II)-catalyzed reactions involving oxidant agents.

Authors:  Egle M Beccalli; Gianluigi Broggini; Michela Martinelli; Silvia Sottocornola
Journal:  Chem Rev       Date:  2007-11-01       Impact factor: 60.622

10.  Highly efficient asymmetric synthesis of sitagliptin.

Authors:  Karl B Hansen; Yi Hsiao; Feng Xu; Nelo Rivera; Andrew Clausen; Michele Kubryk; Shane Krska; Thorsten Rosner; Bryon Simmons; Jaume Balsells; Nori Ikemoto; Yongkui Sun; Felix Spindler; Christophe Malan; Edward J J Grabowski; Joseph D Armstrong
Journal:  J Am Chem Soc       Date:  2009-07-01       Impact factor: 15.419

View more
  1 in total

1.  Cycloadditions of Donor-Acceptor Cyclopropanes and -butanes using S=N-Containing Reagents: Access to Cyclic Sulfinamides, Sulfonamides, and Sulfinamidines.

Authors:  Gwyndaf A Oliver; Maximilian N Loch; André U Augustin; Pit Steinbach; Mohammed Sharique; Uttam K Tambar; Peter G Jones; Christoph Bannwarth; Daniel B Werz
Journal:  Angew Chem Int Ed Engl       Date:  2021-10-29       Impact factor: 16.823

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.